Vivos Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
20 Jun 23 | BuyUS$15,481 | R. Huntsman | Individual | 1,160.84 | US$13.50 | |
14 Jun 23 | BuyUS$4,900 | R. Huntsman | Individual | 400 | US$12.25 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 1,718 | 0.0576% |
Individual Insiders | 201,929 | 6.77% |
Institutions | 221,998 | 7.44% |
Hedge Funds | 595,581 | 20% |
General Public | 1,961,044 | 65.8% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 151.2%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
595,581 | US$1.5m | 240% | 0.04% | |||
128,789 | US$326.4k | 0% | 0.05% | |||
128,788 | US$326.3k | 0% | no data | |||
73,061 | US$185.1k | 0% | no data | |||
50,100 | US$127.0k | 0% | no data | |||
15,000 | US$38.0k | 0% | no data | |||
10,579 | US$26.8k | -57% | no data | |||
8,077 | US$20.5k | 0% | no data | |||
4,000 | US$10.1k | 2,400% | no data | |||
2,365 | US$6.0k | 0.04% | no data | |||
1,950 | US$4.9k | 50.6% | no data | |||
1,718 | US$4.4k | 0% | no data | |||
547 | US$1.4k | 0.18% | no data | |||
388 | US$983.2 | 4,750% | no data | |||
80 | US$202.5 | -90.9% | no data | |||
67 | US$170.0 | 1.52% | no data | |||
49 | US$123.9 | 2.08% | no data | |||
42 | US$106.6 | 2.44% | no data | |||
23 | US$58.2 | 0% | no data | |||
8 | US$20.4 | 0% | no data | |||
7 | US$17.4 | 16.7% | no data | |||
4 | US$9.8 | 0% | no data | |||
3 | US$7.6 | -76.9% | no data |